Caspary L - Search Results

1

Treatment of primary Raynaud's syndrome with traditional Chinese acupuncture.

Appiah R, Hiller S, Caspary L, Alexander K, Creutzig A. Appiah R, et al. J Intern Med. 1997 Feb;241(2):119-24. doi: 10.1046/j.1365-2796.1997.91105000.x. J Intern Med. 1997. PMID: 9077368 Free article. Clinical Trial.

2

Nailfold capillaroscopy and laser Doppler fluxmetry for evaluation of Raynaud's phenomenon: how valid is the local cooling test?

Creutzig A, Hiller S, Appiah R, Thum J, Caspary L. Creutzig A, et al. Vasa. 1997 Aug;26(3):205-9. Vasa. 1997. PMID: 9286153

3

Intravenous infusion of iloprost in arterial occlusive disease: dose-dependent effects on skin microcirculation.

Caspary L, Creutzig A, Alexander K. Caspary L, et al. Eur J Clin Pharmacol. 1991;41(2):131-6. doi: 10.1007/BF00265905. Eur J Clin Pharmacol. 1991. PMID: 1720738

4

Alterations of the nailfold capillary morphology associated with Raynaud phenomenon in patients with systemic lupus erythematosus.

Caspary L, Schmees C, Schoetensack I, Hartung K, Stannat S, Deicher H, Creutzig A, Alexander K. Caspary L, et al. J Rheumatol. 1991 Apr;18(4):559-66. J Rheumatol. 1991. PMID: 2066948

5

Comparison of Laser-Doppler-Flux and tcPO2 in healthy probands and patients with arterial ischemia.

Caspary L, Creutzig A, Alexander K. Caspary L, et al. Adv Exp Med Biol. 1987;220:235-40. doi: 10.1007/978-1-4613-1927-6_43. Adv Exp Med Biol. 1987. PMID: 2960138

6

Intermittent intraarterial infusion therapy with PGE1 in patients with severe claudication--results of a randomized prospective double blind study.

Caspary L, Creutzig A, Radeke U, Specht S, Alexander K. Caspary L, et al. Biomed Biochim Acta. 1988;47(10-11):S307-10. Biomed Biochim Acta. 1988. PMID: 3073766 Clinical Trial.

7

[How often is thrombolytic therapy of deep pelvic-leg venous thrombosis indicated?].

Caspary L, Creutzig A, Alexander K. Caspary L, et al. Med Klin (Munich). 1995 Nov 15;90(11):618-22. Med Klin (Munich). 1995. PMID: 8569627 German.

8

The Raynaud phenomenon and interferon therapy.

Creutzig A, Caspary L, Freund M. Creutzig A, et al. Ann Intern Med. 1996 Sep 1;125(5):423. doi: 10.7326/0003-4819-125-5-199609010-00025. Ann Intern Med. 1996. PMID: 8702103 No abstract available.

9

Microangiopathy in patients with chronic myelogenous leukemia treated with interferon.

Creutzig A, Freund M, Caspary L, Alexander K. Creutzig A, et al. Microvasc Res. 1996 Nov;52(3):288-92. doi: 10.1006/mvre.1996.0066. Microvasc Res. 1996. PMID: 8954870 No abstract available.

10

[Raynaud's phenomenon--current diagnosis and therapy].

Caspary L, Creutzig A. Caspary L, et al. Dtsch Med Wochenschr. 2006 May 26;131(21):1223-7. doi: 10.1055/s-2006-941757. Dtsch Med Wochenschr. 2006. PMID: 16721713 Review. German. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Search Page

Filters